TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
VKTX

Viking Therapeutics Inc

Healthcare · Biotechnology

28.50$ +2.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VKTX
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.13 -0.02 -0.37 -1.37 -0.68 -0.57 -0.33 -0.34 -0.30 -0.62 -0.63 -0.78 -0.81 -2.47
– – 0.13 0.16 0.12 0.05 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.02 0.00 0.00 0.41 0.11 0.06 0.05 0.05 0.08 0.08 0.11 0.18 0.27 0.36
– – -0.51 0.41 0.11 0.06 0.05 0.05 0.08 0.08 0.11 – – –
– 0.01 5.09 0.10 0.05 0.07 0.01 -0.05 0.11 -0.04 0.13 0.04 0.09 0.43
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – -3.13 -2.12 0.19 -0.07 -4.61 0.10 0.57 0.49 0.71 -1.90 -5.08 3.03
– – – 0.00 0.00 0.00 – – – – – – – –
– 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.08 -0.39 –
– – 0.58 -0.01 -0.01 0.00 -0.07 – – – – – – –
0.13 0.06 0.50 3.50 0.64 0.86 5.21 0.01 0.01 0.09 0.05 2.88 5.62 0.68
– 0.04 0.13 0.00 0.14 0.23 0.27 -0.23 0.29 -0.04 0.13 0.20 -0.26 1.23
-0.13 -0.02 -0.37 -1.37 -0.68 -0.57 -0.33 -0.34 -0.30 -0.62 -0.63 -0.78 -0.81 -2.47

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?